Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma

被引：57
|
作者：
Chan, K. C. Allen [1 ,2 ,3 ]
机构：
[1] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Chem Pathol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, State Key Lab Oncol South China, Prince Wales Hosp, Sir YK Pao Ctr Canc, Shatin, Hong Kong, Peoples R China
来源：
CHINESE JOURNAL OF CANCER | 2014年 / 33卷 / 12期
关键词：
Plasma Epstein-Barr virus EBV DNA; tumor markers; nasopharyngeal carcinoma; cancer screening; CIRCULATING EBV DNA; COPY NUMBER ABERRATIONS; VIRAL CAPSID ANTIGEN; CELL-FREE; QUANTITATIVE-ANALYSIS; CANCER-PATIENTS; CLEARANCE RATE; NUCLEIC-ACIDS; SERUM; QUANTIFICATION;
D O I：
10.5732/cjc.014.10192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Nasopharyngeal carcinoma (NPC) is common in southern China and Southeast Asia. Epstein-Barr virus (EBV) infection is an important etiology for NPC, and EBV genome can be detected in almost all tumor tissues of NPC in this region. Plasma EBV DNA, when quantitatively analyzed using real-time polynnerase chain reaction (PCR), has been developed as a biomarker for NPC. In this review, the different clinical applications of plasma EBV DNA in the management of NPC, including screening, monitoring, and prognostication, are discussed. In addition, the biological issues of circulating EBV DNA, including the molecular nature and clearance kinetics, are also explored.
引用
收藏
页码：598 / 603
页数：6
相关论文
共 50 条
  • [1] Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
    K.C.Allen Chan
    [J]. 癌症, 2014, 33 (12) : 598 - 603
  • [2] Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
    Prayongrat, Anussara
    Chakkabat, Chakkapong
    Kannarunimit, Danita
    Hansasuta, Pokrath
    Lertbutsayanukul, Chawalit
    [J]. JOURNAL OF RADIATION RESEARCH, 2017, 58 (04) : 509 - 516
  • [3] The Role of Plasma Epstein-Barr Virus DNA in the Management of Recurrent Nasopharyngeal Carcinoma
    Chan, Jimmy Yu Wai
    Wong, Stanley Thian-Sze
    [J]. LARYNGOSCOPE, 2014, 124 (01): : 126 - 130
  • [4] Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
    Lin, JC
    Wang, WY
    Chen, KY
    Wei, YH
    Liang, WM
    Jan, JS
    Jiang, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (24): : 2461 - 2470
  • [5] Epstein-Barr virus and nasopharyngeal carcinoma
    Lawrence S.Young
    Christopher W.Dawson
    [J]. 癌症, 2014, 33 (12) : 581 - 590
  • [6] THE EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA
    TARR, KL
    GLASER, R
    [J]. MICROBIAL PATHOGENESIS, 1989, 7 (01) : 11 - 14
  • [7] Epstein-Barr virus and nasopharyngeal carcinoma
    Young, Lawrence S.
    Dawson, Christopher W.
    [J]. CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 581 - 590
  • [8] Epstein-Barr virus DNA detection in the diagnosis of nasopharyngeal carcinoma
    Yap, Yoke-Yeow
    Hassan, Shahid
    Chan, Melissa
    Choo, Pua Kin
    Ravichandran, Manickam
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (06) : 986 - 991
  • [9] Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma
    Reinhard E. Friedrich
    Sylva Bartel-Friedrich
    Hartmut Lobeck
    Gerald Niedobitek
    Hartmut Arps
    [J]. Medical Microbiology and Immunology, 2003, 192 : 141 - 144
  • [10] Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma
    Friedrich, RE
    Bartel-Friedrich, S
    Lobeck, H
    Niedobitek, G
    Arps, H
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2003, 192 (03) : 141 - 144
12345